16 articles for BN Sinha
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis.
Birla Institute of Technology
Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity.
Birla Institute of Technology
Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis.
Weill Medical College of Cornell University
Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.
Birla Institute of Technology
Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
Institute of Technology
Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
Institute of Technology
Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models.
Sterling Road
A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
Birla Institute of Technology
Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy.
De Montfort University
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.
Birla Institute of Technology
Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
Birla Institute of Technology
Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads.
Gvk Biosciences
